Literature DB >> 27334206

Therapy: Patients with TRAPS respond to canakinumab.

Caroline Barranco.   

Abstract

Entities:  

Year:  2016        PMID： 27334206     DOI： 10.1038/nrrheum.2016.106

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.

Authors:  Marco Gattorno; Laura Obici; Marco Cattalini; Vincent Tormey; Ken Abrams; Nicole Davis; Antonio Speziale; Suraj G Bhansali; Alberto Martini; Helen J Lachmann
Journal:  Ann Rheum Dis       Date:  2016-06-07       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.